Tecirlioglu R Tayfur, Cooney Melissa A, Lewis Ian M, Korfiatis Natasha A, Hodgson Renee, Ruddock Nancy T, Vajta Gábor, Downie Shara, Trounson Alan O, Holland Michael K, French Andrew J
Centre for Early Human Development, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Reprod Fertil Dev. 2005;17(5):573-85. doi: 10.1071/rd04122.
The aim of the present study was to compare the in vitro and in vivo developmental competence of hand-made cloning (HMC) embryos with the conventional nuclear transfer (NT) method using five somatic cell lines and in vitro-fertilised (IVF; control) embryos. Modifications to the HMC procedure included fusion efficiency optimisation, effect of cytoplasmic volume and cloned embryo aggregation. The developmental competence of blastocysts from each of the treatment groups and cell lines used was assessed following transfer to 345 recipients. Vitrification was also used to enable management of recipient resources and to assess the susceptibility of membranes to cryopreservation following zona removal. Increasing cytoplasmic volume to 150% or aggregating two embryos improved the blastocyst development rate and increased the total cell number. Although HMC embryo transfers established a significantly higher pregnancy rate on Day 30 than fresh IVF or NT embryo transfers, the overall outcome in terms of cloned live births derived from either fresh or vitrified/thawed HMC or NT embryo transfers across the five cell lines did not differ. The birth and continued survival of clones produced with HMC technology with equivalent efficiency to NT shows that it can be used as an alternative method for the generation of cloned offspring in the bovine.
本研究的目的是使用五种体细胞系,比较手工克隆(HMC)胚胎与传统核移植(NT)方法以及体外受精(IVF;对照)胚胎在体外和体内的发育能力。对HMC程序的改进包括融合效率优化、细胞质体积的影响以及克隆胚胎聚集。将每个处理组和所用细胞系的囊胚转移至345只受体后,评估其发育能力。还使用玻璃化技术来管理受体资源,并评估去除透明带后膜对冷冻保存的敏感性。将细胞质体积增加到150%或使两个胚胎聚集可提高囊胚发育率并增加总细胞数。尽管在第30天,HMC胚胎移植的妊娠率显著高于新鲜IVF或NT胚胎移植,但在这五种细胞系中,无论是新鲜的还是玻璃化/解冻的HMC或NT胚胎移植所产生的克隆活产的总体结果并无差异。采用HMC技术产生的克隆体与NT具有同等效率,其出生及持续存活表明,HMC技术可作为牛克隆后代的一种替代方法。